Cure JM September 2025 – Virtual Summit

Cure JM Virtual Summit on Juvenile Idiopathic Inflammatory Myopathies

September 25, 2025

In September, the Cure JM Clinical Care Network was pleased to invite juvenile dermatomyositis healthcare professionals to join us virtually for the latest presentations from world-leading researchers and clinicians on advancements in basic research, translational studies, and best-practice clinical care in juvenile dermatomyositis.

This event featured sessions on various topics, with the primary goal of enhancing the overall patient and provider experience through collaboration and sharing of best practices.

Intended Audience:

Any clinician or researcher interested in IIM research or care
Pediatric and adult rheumatologists, dermatologists, and immunologists
Residents and fellows
Professors dermatomyositis, polymyositis, and related fields of study
HCPs who treat autoimmune conditions in adults or juveniles
Industry representatives

We are pleased to share each presentation and outcomes from each session below:

Welcome and Introductory Comments, Dr. Andrew Heaton, Cure JM CSO.

Updating the SHARE Guidance Publication on Treatment for JM Patients. Dr. Liza McCann, Consultant Pediatric Rheumatologist, Alder Hey Hospital, Liverpool, UK, Honorary Clinical Associate Professor, University of Liverpool, UK.

Transition: Navigating Pediatric to Adult Rheumatology Care. Dr. Rebecca Sadun, Associate Professor of Medicine, Associate Professor of Pediatrics, Duke University School of Medicine, USA.

Expert Panel Discussion on Selected JM Cases feat.

Dr Lisa Rider, Head and Senior Clinician, Environmental Autoimmunity Group, NIEHS, National Institutes of Health, Bethesda, MD, USA
Dr. Stacey Tarvin, Associate Professor of Clinical Pediatrics, Indiana University School of Medicine, USA.
Dr. Susan Kim, Prof of Pediatrics UCSF School of Medicine, USA
Dr. Susan Shenoi, Prof of Pediatrics, University of Washington, USA
Dr. Brian Feldman, Head of Division of Rheumatology, Hospital for SickKids, Toronto, Canada

Additional Clinician-Facing Resources https://www.curejm.org/clinicians/

Find us on Facebook https://www.facebook.com/curejm

Juvenile dermatomyositis patient Natalia with Dr. Liebling, JDM researcher

Research Volunteers and Assistance Needed

Help researchers find the cause and a cure for juvenile myositis by volunteering for these important studies.

Town Hall October 2024, Calcinosis, Christian Lood

What We Know About Calcinosis & How to Treat It

Medically Reviewed by Angela Chun, MD on February 9, 2026 and Belina Yi, DO on February 25, 2026. Cure JM shares medical resources to support informed conversations

Early Promising Data Presented in Car-T for Myositis

Cabaletta Bio Presents Promising Early Data on CAR-T Therapy for Myositis

We expected to hear promising news about the potential for CAR-T therapy to treat myositis at the Global Conference on Myositis (GCOM).

What we heard was more than promising—it was astounding.

What if I told you that there was a therapy that would “reset” the immune system—virtually eliminating the autoimmune response in myositis that causes inflammation, pain, muscle weakness, and other JM conditions of which we are all too familiar.

Join Cure JM

Membership is free and we’ll connect you with a network of support, encouragement, and resources.

Cure JM September 2025 – Virtual Summit

Research Volunteers and Assistance Needed

What We Know About Calcinosis & How to Treat It

Cabaletta Bio Presents Promising Early Data on CAR-T Therapy for Myositis

Join Cure JM

Families

Physicians

Cure JM

Get Involved

Interested in DIY fundraising but need help?

We’re here to help!